Generic Medicines Working Group - 28 November 2017

Page last updated: 10 October 2018

Attendees included representatives from the Generic and Biosimilar Medicines Association, industry and the Department of Health.

The scope for the PBS Transparency and Efficiencies subgroup and the Biosimilar Policy subgroup were endorsed.

The Department committed to provide regular updates to GBMA on the status of legislative changes to deliver the increased threshold for price disclosure and the changes to e-prescribing.

Members agreed to progress work out of session where required.

PDF version of Generic Medicines Working Group Communique 28 November 2017 (122 KB)